# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-122804
Filing Date
2024-11-07
Accepted
2024-11-07 07:30:26
Documents
85
Period of Report
2024-09-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | aplt-20240930.htm iXBRL | 10-Q | 2432217
2 | EX-31.1 | aplt-ex31_1.htm | EX-31.1 | 10771
3 | EX-31.2 | aplt-ex31_2.htm | EX-31.2 | 14275
4 | EX-32.1 | aplt-ex32_1.htm | EX-32.1 | 6083
5 | EX-32.2 | aplt-ex32_2.htm | EX-32.2 | 6314
| Complete submission text file | 0000950170-24-122804.txt |  | 9410296

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | aplt-20240930.xsd | EX-101.SCH | 1398687
87 | EXTRACTED XBRL INSTANCE DOCUMENT | aplt-20240930_htm.xml | XML | 1472520

Mailing Address 545 FIFTH AVENUE, SUITE 1400 NEW YORK NY 10017
Business Address 545 FIFTH AVENUE, SUITE 1400 NEW YORK NY 10017 212-220-9226
Applied Therapeutics, Inc. (Filer) CIK: 0001697532 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38898 | Film No.: 241433184
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)